Factors associated with human papillomavirus (HPV) test acceptability in primary screening for cervical cancer: A mixed methods research synthesis

被引:24
|
作者
Tatar, Ovidiu [1 ]
Thompson, Erika [2 ]
Naz, Anila [1 ]
Perez, Samara [1 ,3 ]
Shapiro, Gilla K. [1 ,3 ]
Wade, Kristina [1 ]
Zimet, Gregory [4 ]
Gilca, Vladimir [5 ]
Janda, Monika [6 ]
Kahn, Jessica [7 ]
Daley, Ellen [8 ]
Rosberger, Zeev [1 ,3 ]
机构
[1] Jewish Gen Hosp, Lady Davis Inst Med Res, 4333 Cote Ste Catherine Rd, Montreal, PQ H3T 1E4, Canada
[2] Univ North Texas, Hlth Sci Ctr, Sch Publ Hlth, Dept Hlth Behav & Hlth Syst, 3500 Camp Bowie,EAD 709M, Ft Worth, TX 76107 USA
[3] McGill Univ, Dept Psychol, 2001 McGill Coll, Montreal, PQ, Canada
[4] Indiana Univ Sch Med, Sect Adolescent Med, 410 West 10th St,HS 1001, Indianapolis, IN 46202 USA
[5] Inst Natl Sante Publ Quebec, 945 Wolfe Ave, Quebec City, PQ G1V 5B3, Canada
[6] Queensland Univ Technol, Fac Hlth, Brisbane, Qld, Australia
[7] Univ Cincinnati Ohio, Cincinnati Childrens Hosp Med Ctr, Div Adolescent & Transit Med, MLC 4000,3333 Burnet Ave, Cincinnati, OH 45229 USA
[8] Univ S Florida, Dept Community & Family Hlth, 13201 Bruce B Downs Blvd,MDC 56, Tampa, FL 33612 USA
关键词
Human papillomavirus; Uterine Cervical Neoplasms; Mass Screening; Psychology; Human Papillomavirus DNA Tests; Review; Mixed methods; Barriers; Facilitators; Psychosocial; INTRAEPITHELIAL NEOPLASIA; QUALITY-ASSURANCE; DECISION-MAKING; FOLLOW-UP; KNOWLEDGE; WOMEN; INFORMATION; VACCINATION; PREFERENCES; PREDICTORS;
D O I
10.1016/j.ypmed.2018.08.034
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Primary screening for cervical cancer is transitioning from the longstanding Pap smear towards implementation of an HPV-DNA test, which is more sensitive than Pap cytology in detecting high-risk lesions and offers greater protection against invasive cervical carcinomas. Based on these results, many countries are recommending and implementing HPV testing-based screening programs. Understanding what factors (e.g., knowledge, attitudes) will impact on HPV test acceptability by women is crucial for ensuring adequate public health practices to optimize cervical screening uptake. We used mixed methods research synthesis to provide a categorization of the relevant factors related to HPV primary screening for cervical cancer and describe their influence on women's acceptability of HPV testing. We searched Medline, Embase, PsycINFO, CINAHL, Global Health and Web of Science for journal articles between January 1, 1980 and October 31, 2017 and retained 22 empirical articles. Our results show that while most factors associated with HPV test acceptability are included in the Health Belief Model and/or Theory of Planned Behavior (e.g., attitudes, knowledge), other important factors are not encompassed by these theoretical frameworks (e.g., health behaviors, negative emotional reactions related to HPV testing). The direction of influence of psychosocial factors on HPV test acceptability was synthesized based on 14 quantitative studies as: facilitators (e.g., high perceived HPV test benefits), barriers (e.g., negative attitudes towards increased screening intervals), contradictory evidence (e.g., sexual history) and no impact (e.g., high perceived severity of HPV infection). Further population-based studies are needed to confirm the impact of these factors on HPV-based screening acceptability.
引用
收藏
页码:40 / 50
页数:11
相关论文
共 50 条
  • [31] The value of human papillomavirus detection in primary cervical cancer screening
    Baay, MFD
    Weyler, J
    Vermorken, JB
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2004, 25 (06) : 665 - 669
  • [32] Primary HPV test screening in cervical cancer: a two-year experience of a single screening center in Latina (Italy)
    Chiappetta, C.
    Lendaro, E.
    Cacciotti, J.
    Zaralli, R.
    Puggioni, C.
    Migliore, G.
    Bellardini, P.
    Porta, N.
    Petrozza, V.
    Della Rocca, C.
    Di Cristofano, C.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2015, 36 (05) : 569 - 573
  • [33] Implementation of human papillomavirus primary screening for cervical cancer in BC
    Gentile, Laura
    Smith, Laurie W.
    Smith, Brenda
    Ogilvie, Gina
    Proctor, Lily
    BRITISH COLUMBIA MEDICAL JOURNAL, 2024, 66 (10): : 375 - 380
  • [34] Predictors of Human papillomavirus (HPV) persistence after treatment of high grade cervical lesions; does cervical cytology have any prognostic value in primary HPV screening?
    Kilic, Derya
    Guler, Tolga
    Atigan, Ayhan
    Avsaroglu, Elif
    Karakaya, Yeliz Arman
    Kaleli, Ilknur
    Kaleli, Babur
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2020, 49
  • [35] Clinical performance of the Roche Cobas 4800 HPV test for primary cervical cancer screening in a Chinese population
    Liu, Stephanie S.
    Chan, Karen K. L.
    Wei, Tina N.
    Tse, Ka Yu
    Ngu, Siew F.
    Chu, Mandy M. Y.
    Lau, Lesley S. K.
    Cheung, Annie N. Y.
    Ngan, Hextan Y. S.
    PLOS ONE, 2022, 17 (08):
  • [36] 2020 list of human papillomavirus assays suitable for primary cervical cancer screening
    Arbyn, Marc
    Simon, Marie
    Peeters, Eliana
    Xu, Lan
    Meijer, Chris J. L. M.
    Berkhof, Johannes
    Cuschieri, Kate
    Bonde, Jesper
    Vanlencak, Anja Ostrbenk
    Zhao, Fang-Hui
    Rezhake, Remila
    Gultekin, Murat
    Dillner, Joakim
    de Sanjose, Silvia
    Canfell, Karen
    Hillemanns, Peter
    Almonte, Maribel
    Wentzensen, Nicolas
    Poljak, Mario
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (08) : 1083 - 1095
  • [37] Factors associated to the human papillomavirus in women with cervical cancer
    Guedes, Daiany Helena Stein
    Fiorin, Bruno Henrique
    Santos, Marcos Vinicius Ferreira dos
    Viana, Katia Cirlene Gomes
    Portugal, Flavia Batista
    Silva, Renan Alves
    REV RENE, 2020, 21
  • [38] Human papillomavirus (HPV) DNA and mRNA primary cervical cancer screening: Evaluation and triaging options for HPV-positive women
    Sangrajrang, Suleeporn
    Laowahutanont, Piyawat
    Wongsena, Metee
    Muwonge, Richard
    Imsamran, Weerawut
    Ploysawang, Pattama
    Basu, Partha
    JOURNAL OF MEDICAL SCREENING, 2019, 26 (04) : 212 - 218
  • [39] Human papillomavirus (HPV) screening and cervical cancer burden. A Brazilian perspective
    Lorenzi, Adriana T.
    Syrjanen, Kari J.
    Longatto-Filho, Adhemar
    VIROLOGY JOURNAL, 2015, 12
  • [40] The Role of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Large-Scale Evaluation of the cobas HPV Test
    Schiffman, Mark
    Boyle, Sean
    Raine-Bennett, Tina
    Katki, Hormuzd A.
    Gage, Julia C.
    Wentzensen, Nicolas
    Kornegay, Janet R.
    Apple, Raymond
    Aldrich, Carrie
    Erlich, Henry A.
    Tam, Thanh
    Befano, Brian
    Burk, Robert D.
    Castle, Philip E.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2015, 24 (09) : 1304 - 1310